Detalhe da pesquisa
1.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090602
2.
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240755
3.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1305-1320, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121899
4.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Nat Cancer
; 2: 1321-1337, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950880
5.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(4): 438, 2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413273
6.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(2): 114-116, 2022 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968417
7.
The potential of decision support systems to improve risk assessment for pollen beetle management in winter oilseed rape.
Pest Manag Sci
; 72(3): 609-17, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112069